Hemoglobinuria, paroxysmal Clinical Trials
Conditions / Hemoglobinuria, paroxysmal
Delta Trials records 15 clinical trials for Hemoglobinuria, paroxysmal in its publicly accessible dataset. From the full dataset, 0 actively seeking eligible participants and 9 trials have reached completion. This research is conducted across 62 study locations around the world. An additional 6 trials are active but not currently open for enrollment. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.
Trial Status
15
Total Trials
0
Recruiting
9
Completed
6
Other Active
0
Terminated since 2020
62
Study Locations
Browse by location (62 total)
- Basel, Switzerland 3 trialsAll trials in Basel, Switzerland
- Bethesda, United States 3 trialsAll trials in Bethesda, United States
- Cleveland, United States 3 trialsAll trials in Cleveland, United States
- Los Angeles, United States 3 trialsAll trials in Los Angeles, United States
- Indianapolis, United States 3 trialsAll trials in Indianapolis, United States
- Hanover, Germany 2 trialsAll trials in Hanover, Germany
- Weston, United States 2 trialsAll trials in Weston, United States
- St. Louis, United States 2 trialsAll trials in St. Louis, United States
- St. Louis, United States 2 trialsAll trials in St. Louis, United States
- Tianjin, China 2 trialsAll trials in Tianjin, China
- Leeds, United Kingdom 2 trialsAll trials in Leeds, United Kingdom
- Homburg/saar, Germany 2 trialsAll trials in Homburg/saar, Germany
- London, United Kingdom 2 trialsAll trials in London, United Kingdom
- Nijmegen, Netherlands 2 trialsAll trials in Nijmegen, Netherlands
- Homburg/ Saar, Germany 2 trialsAll trials in Homburg/ Saar, Germany
- Napoli, Italy 2 trialsAll trials in Napoli, Italy
- Hartford, United States 2 trialsAll trials in Hartford, United States
- Homburg (saar), Germany 2 trialsAll trials in Homburg (saar), Germany
- Homburg / Saar, Germany 2 trialsAll trials in Homburg / Saar, Germany
- Edmonton, Canada 2 trialsAll trials in Edmonton, Canada